Skip to main content
. 2018 Jul 31;315(5):H1148–H1158. doi: 10.1152/ajpheart.00726.2017

Fig. 3.

Fig. 3.

Myocardial infarct size expressed as a percentage of the area at risk (A) and relationship between area at risk and infarct size, both expressed as a percentage of the left ventricle (B), in rats administrated vehicle, the epoxyeicosatrienoic acid (EET) analog EET-B (2.5 mg/kg iv) or 14,15-EET (2.5 mg/kg iv) 5 min before reperfusion, or the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE; 2.5 mg/kg iv) alone or combined with EET-B 10 min before reperfusion. Values are expressed as means ± SE from 6−9 rats. *P < 0.05 vs. vehicle; †P < 0.05 vs. EET-B.